| Financial Year |
March 31 2023 |
| Monetary Funds |
762,311,479.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,607,481,597.40 |
| Advances to Suppliers |
567,768,316.92 |
| Other Receivables |
43,740,053.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,663,158,877.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
38,284,849.18 |
| Other Current Assets |
33,942,897.92 |
| Total Current Assets |
8,011,690,769.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
67,347,279.83 |
| Long-term Equity Investment |
33,952,294.99 |
| Investment Properties |
31,084,561.82 |
| Fixed Assetes |
1,427,279,830.24 |
| Under-construction Projects |
83,932,419.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,701,585.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,990,494.81 |
| Deferred Income Tax Assets |
47,020,601.55 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,853,435,974.82 |
| Total Assets |
9,865,126,744.30 |
| Short-Term Loans |
2,347,726,857.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,049,424,305.54 |
| Accounts Payable |
2,501,133,916.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,087,112.40 |
| Taxes Payable |
38,154,988.35 |
| Interest Payable |
9,784,863.61 |
| Dividend Payable |
9,592,185.48 |
| Other payables |
65,899,769.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,659,093.32 |
| Other Current Liabilities |
13,076,321.52 |
| Sub-Total of Current Liabilities |
6,687,927,999.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
54,880,412.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
804,066.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,775,306.07 |
| Total Liabilities |
6,790,703,305.67 |
| Paid-In Capital(Or Share Stock) |
941,003,689.00 |
| Capital Surplus |
1,642,265,296.71 |
| Surplus Reserve |
187,509,298.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
132,749,167.66 |
| Minority Stockholder's Interest |
150,306,625.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,924,116,812.94 |
| Owner's Equity（Stockholder's Equity） |
3,074,423,438.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,865,126,744.30 |
